Masimo Corp (MASI)
124.10
+3.49
(+2.89%)
USD |
NASDAQ |
May 17, 16:00
123.98
-0.12
(-0.10%)
After-Hours: 20:00
Masimo Research and Development Expense (Annual): 175.20M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 175.20M |
| December 31, 2022 | 191.40M |
| December 31, 2021 | 137.20M |
| December 31, 2020 | 118.70M |
| December 31, 2019 | 93.30M |
| December 31, 2018 | 81.01M |
| December 31, 2017 | 65.23M |
| December 31, 2016 | 57.69M |
| December 31, 2015 | 56.62M |
| December 31, 2014 | 56.58M |
| December 31, 2013 | 55.63M |
| Date | Value |
|---|---|
| December 31, 2012 | 47.08M |
| December 31, 2011 | 38.41M |
| December 31, 2010 | 36.00M |
| December 31, 2009 | 31.70M |
| December 31, 2008 | 25.50M |
| December 31, 2007 | 22.96M |
| December 31, 2006 | 24.88M |
| December 31, 2005 | 8.548M |
| December 31, 2004 | |
| December 31, 2003 | 4.567M |
| December 31, 2002 | 4.369M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
93.30M
Minimum
2019
191.40M
Maximum
2022
143.16M
Average
137.20M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Integer Holdings Corp | 63.77M |
| Stryker Corp | 1.388B |
| Insulet Corp | 205.00M |
| Shockwave Medical Inc | 145.65M |